Caroline C. Pt Azevedo
Caroline C. Pt Azevedo has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Acioly Luiz Tavares Lacerda
PRODAF—Programa de Transtornos Afetivos, Department of Psychiatry, Universidade Federal de São Paulo, Brazil
1 shared publication - Adriane Viapiana Bossa
Centro Universitário de Tecnologia de Curitiba - UNIFATECCentro Universitário de Tecnologia de Curitiba - UNIFATEC. Curitiba, PR. Brasil
1 shared publication Alisson Paulino Trevizol
Temerty Centre for Therapeutic Brain Intervention and Campbell Family Research Institute, Centre for Addiction and Mental Health
1 shared publicationAlvaro M. PsyD Dias
Institute of Psychology University of São Paulo, São Paulo, Brazil
1 shared publication- Angela Mara Rambo
Centro Universitário de Tecnologia de Curitiba - UNIFATECCentro Universitário de Tecnologia de Curitiba - UNIFATEC. Curitiba, PR. Brasil
1 shared publication - Ary Gadelha
Department of Psychiatry, Universidade Federal de São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 12 September 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Medicina
- Vol. 103 (5)
Biomagnetismo medicinal na hepatite autoimune: um estudo de caso
A Hepatite Autoimune (HAI) é uma doença crônica e inflamatória grave do fígado causada pela perda da tolerância aos autoantígenos hepatoespecíficos, onde a identificação é feita aplicando escores diagnóstico. É caracterizada por aumento de aminotransferases séricas - aspartato aminotransferase (AST) e alanina aminotransferase (ALT), imunoglobulina G, autoanticorpos, onde há aparecimento de agentes gatilhos que confundem o sistema imunológico que reconhecem como antígeno componentes de alguns hepatócitos. Neste estudo foi aplicado o Biomagnetismo Medicinal (BM) que é um método de tratamento desenvolvido pelo Dr. Isaac Goiz Durán (1941-2021), cuja técnica consiste na aplicação de um par de ímãs de média intensidade - 1.000 a 7.500 Gauss, com polaridades opostas que entram em ressonância entre si e objetivam a despolarização do campo magnético disfuncional chamado Par Biomagnético (PBM). A ressonância magnética gerada pelos campos magnéticos estáticos, identifica e restabelece a disfunção do spin* dos elétrons, dos elementos bioquímicos que suportam a distorção de potencial hidrogeniônico (pH). Os objetivos deste estudo foram: investigar se houve alteração dos sinais clínicos e laboratoriais da participante submetida ao BM; investigar a aplicabilidade da técnica na sua evolução clínica; comparar possíveis alterações de pH da saliva antes e após a terapia; observar se houve alterações das enzimas hepáticas no período do tratamento; averiguar se ao longo do tratamento o hepatologista indicou a redução na dosagem da medicação em vista da melhora clínica/ laboratorial e se houve melhora da sintomatologia. Através da análise dos registros do prontuário observou-se que a técnica do BM possibilitou a melhora do quadro clínico/laboratorial da participante com HAI.
- 12 September 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Revista de Medicina
- Vol. 103 (5)
Open AccessBiomagnetismo medicinal na hepatite autoimune: um estudo de caso
A Hepatite Autoimune (HAI) é uma doença crônica e inflamatória grave do fígado causada pela perda da tolerância aos autoantígenos hepatoespecíficos, onde a identificação é feita aplicando escores diagnóstico. É caracterizada por aumento de aminotransferases séricas - aspartato aminotransferase (AST) e alanina aminotransferase (ALT), imunoglobulina G, autoanticorpos, onde há aparecimento de agentes gatilhos que confundem o sistema imunológico que reconhecem como antígeno componentes de alguns hepatócitos. Neste estudo foi aplicado o Biomagnetismo Medicinal (BM) que é um método de tratamento desenvolvido pelo Dr. Isaac Goiz Durán (1941-2021), cuja técnica consiste na aplicação de um par de ímãs de média intensidade - 1.000 a 7.500 Gauss, com polaridades opostas que entram em ressonância entre si e objetivam a despolarização do campo magnético disfuncional chamado Par Biomagnético (PBM). A ressonância magnética gerada pelos campos magnéticos estáticos, identifica e restabelece a disfunção do spin* dos elétrons, dos elementos bioquímicos que suportam a distorção de potencial hidrogeniônico (pH). Os objetivos deste estudo foram: investigar se houve alteração dos sinais clínicos e laboratoriais da participante submetida ao BM; investigar a aplicabilidade da técnica na sua evolução clínica; comparar possíveis alterações de pH da saliva antes e após a terapia; observar se houve alterações das enzimas hepáticas no período do tratamento; averiguar se ao longo do tratamento o hepatologista indicou a redução na dosagem da medicação em vista da melhora clínica/ laboratorial e se houve melhora da sintomatologia. Através da análise dos registros do prontuário observou-se que a técnica do BM possibilitou a melhora do quadro clínico/laboratorial da participante com HAI.
- 1 October 2020
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 37 (1) , 58-63
Transcranial Direct Current Stimulation for Prader-Willi Syndrome
Background: Given the limited therapeutic options for Prader-Willi syndrome (PWS), we conducted an open-label clinical trial to evaluate the effects of transcranial direct current stimulation (tDCS) for hyperphagia, food craving, and aberrant behaviors on this population. Methods: Twelve subjects with PWS (11–35 years old) were included. The subjects underwent 10 daily 20-minute sessions of tDCS in 2 weeks. The anode was positioned over the left dorsolateral prefrontal cortex, and the cathode over the contralateral region. Results: We observed amelioration of hyperphagic and food craving symptoms (P < 0.05), as well as amelioration of behavioral symptoms measured with the Aberrant Behavior Checklist (P < 0.05). Discussion: To our knowledge, this is the first proof-of-concept trial to report the positive effects of increasing excitability of the left dorsolateral prefrontal cortex, using tDCS, for the behavioral, hyperphagia, and food craving symptoms in PWS, which is a low-cost, well-studied, safe alternative for brain stimulation.
- 1 October 2020
- Published by Wolters Kluwer Health in The Journal of ECT
- Vol. 37 (1) , 58-63
Transcranial Direct Current Stimulation for Prader-Willi Syndrome
Background: Given the limited therapeutic options for Prader-Willi syndrome (PWS), we conducted an open-label clinical trial to evaluate the effects of transcranial direct current stimulation (tDCS) for hyperphagia, food craving, and aberrant behaviors on this population. Methods: Twelve subjects with PWS (11–35 years old) were included. The subjects underwent 10 daily 20-minute sessions of tDCS in 2 weeks. The anode was positioned over the left dorsolateral prefrontal cortex, and the cathode over the contralateral region. Results: We observed amelioration of hyperphagic and food craving symptoms (P < 0.05), as well as amelioration of behavioral symptoms measured with the Aberrant Behavior Checklist (P < 0.05). Discussion: To our knowledge, this is the first proof-of-concept trial to report the positive effects of increasing excitability of the left dorsolateral prefrontal cortex, using tDCS, for the behavioral, hyperphagia, and food craving symptoms in PWS, which is a low-cost, well-studied, safe alternative for brain stimulation.
- Open Access
- 5 April 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 199
Evaluation of the efficacy of transcranial direct current stimulation in the treatment of cognitive symptomatology in the early stages of psychosis: study protocol for a double-blind randomized controlled trial
Cognitive deficits are core symptoms of schizophrenia that occur from the early stages of the disorder. There is reliable evidence that cognitive deficits are associated with outcomes in schizophrenia; thus, early treatment could be particularly important. Studies with different neuromodulation techniques involving subjects with schizophrenia suggest that application of transcranial direct current stimulation (tDCS) with inhibitory stimulation over the left temporo-parietal cortex and excitatory stimulation over the left dorsolateral prefrontal cortex could ameliorate positive, negative, and cognitive symptoms. The aim of the present study protocol is to evaluate the efficacy of tDCS in the treatment of cognitive symptomatology in the early stages of psychosis. Seventy patients in the early stages of psychosis will be randomly allocated to receive 20 min of active 2-mA tDCS or sham stimulation once a day for 10 consecutive weekdays. The anode will be placed over the left dorsolateral prefrontal cortex and the cathode over the left temporo-parietal cortex. Neuropsychological and psychiatric assessments will be performed at baseline and at 1 and 3 months following the end of the intervention (sustained effect). The development and utilization of potentially effective neuroenhancement tools such as the non-invasive brain stimulation technique tDCS for the treatment and rehabilitation of cognitive impairment in the early stages of schizophrenia may contribute to improving outcomes of the disorder and eventually provide a further understanding of the nature of the complex and dynamic neural processes underlying those abnormalities. ClinicalTrials.gov, NCT03071484 . Registered on 7 March 2017.
- 5 April 2019
- Published by Springer Nature in Trials
- Vol. 20 (1) , 199
Open AccessEvaluation of the efficacy of transcranial direct current stimulation in the treatment of cognitive symptomatology in the early stages of psychosis: study protocol for a double-blind randomized controlled trial
Cognitive deficits are core symptoms of schizophrenia that occur from the early stages of the disorder. There is reliable evidence that cognitive deficits are associated with outcomes in schizophrenia; thus, early treatment could be particularly important. Studies with different neuromodulation techniques involving subjects with schizophrenia suggest that application of transcranial direct current stimulation (tDCS) with inhibitory stimulation over the left temporo-parietal cortex and excitatory stimulation over the left dorsolateral prefrontal cortex could ameliorate positive, negative, and cognitive symptoms. The aim of the present study protocol is to evaluate the efficacy of tDCS in the treatment of cognitive symptomatology in the early stages of psychosis. Seventy patients in the early stages of psychosis will be randomly allocated to receive 20 min of active 2-mA tDCS or sham stimulation once a day for 10 consecutive weekdays. The anode will be placed over the left dorsolateral prefrontal cortex and the cathode over the left temporo-parietal cortex. Neuropsychological and psychiatric assessments will be performed at baseline and at 1 and 3 months following the end of the intervention (sustained effect). The development and utilization of potentially effective neuroenhancement tools such as the non-invasive brain stimulation technique tDCS for the treatment and rehabilitation of cognitive impairment in the early stages of schizophrenia may contribute to improving outcomes of the disorder and eventually provide a further understanding of the nature of the complex and dynamic neural processes underlying those abnormalities. ClinicalTrials.gov, NCT03071484 . Registered on 7 March 2017.